Pyrilutamide is in phase II clinical trials for the treatment of androgenetic alopecia. It is being developed by Kintor Pharmaceuticals. GlobalData’s drug-specific PTSR and LoA benchmarks are available in the Pyrilutamide LoA Report.
Suzhou Kintor Pharmaceuticals (HKEx: 9939) is a clinical-stage biotechnology company focused on discovering and developing innovative small molecules targeting androgen receptor related diseases. Its product portfolio includes Proxalutamide, KX-826, GT90001 and Destorsertib.
How to Buy
KX-826, also known as Buy pyrilutamide Europe or Pyri, is a new chemical developed by Kintor Pharmaceuticals. This is a company that focuses on developing small-molecule drugs targeting androgen receptor-related diseases. This includes prostate, breast, and liver cancer as well as hair loss in men. The drug is currently in a Phase II clinical trial for androgenic alopecia.
The trials will be conducted over 24 weeks across more than 26 hospitals. It is expected to enroll over 400 patients. The drug will be measured by a change in target area hair count.
GlobalData provides drug-specific PTSR and LoA benchmarks based on 18 years of historical drug development data. This data is used to create indication benchmarks, which are then used to determine a drug’s PTSR and likelihood of approval.
Pyrilutamide, also known as KX-826, is an antiandrogen that blocks DHT and testosterone from binding to the androgen receptor in hair follicles. It is in development for androgenic alopecia and has completed phase II clinical trials in both the US and China. Kintor Pharmaceuticals is also developing a topical formulation of the drug, Ru58841, for acne vulgaris.
Anecdotal reports of Pyrilutamide are mixed, with some people experiencing regrowth and others noticing no effect. However, there are many factors to consider when evaluating anecdotal reports. It is important to note that these reports are based on small sample sizes and only a few users.
Kintor Pharmaceuticals is a clinical stage company that discovers and develops novel small molecule therapeutics targeting cancer and other androgen receptor related diseases. The company’s products include Proxalutamide (GT0918), Buy pyrilutamide in Europe, Destorsertib, ALK-1 and GT20029. The company markets its products in Taiwan, Hong Kong, the US and China. Kintor Pharmaceuticals’ drugs have advanced through the clinical development stage and into the phase III trial period for a variety of indications. To learn more about Kintor Pharmaceuticals and its pipeline, buy GlobalData’s Pyrilutamide LoA Report.
PyriPure is a 0.5% solution of pyrilutamide in a propylene glycol and ethanol vehicle. It is >99% pure and has been confirmed by a 3rd party lab. Each bottle comes with a calibrated pipette for accurate usage.
KX-826, also known as pyrilutamide, is an androgen receptor antagonist being developed by Kintor Pharmaceuticals. It is in phase II clinical trials for androgenic alopecia in the US and China.
Kintor Pharmaceutical is a biotechnology company that discovers and develops drugs for androgen receptor-related disease areas without effective treatments. GlobalData provides drug-specific PTSR and LoA benchmarks for Phase II drugs based on 18 years of historical data. Buy a report now to learn more.
Pyrilutamide is a powerful topical anti-androgen with a potency that exceeds all other commercially available products. It is in phase II clinical trials in the US and China for androgenic alopecia and has shown great promise.
Kintor Pharmaceuticals carries out research and development operations to discover medicine and drugs for prostate, cancer, blood and liver disease and alopecia. It also focuses on androgen receptor-related disease areas lacking effective treatments. It carters its medicines across Taiwan, Hong Kong, the Us, Brazil and China.
The raw material pyrilutamide (KX-826) used in the 0.5% solution is tested and confirmed >99% pure by a 3rd party lab. PyriPure is packaged in a safe propylene glycol and ethanol vehicle and comes with a graduated plastic 1ml pipette for more accurate measurements. It is recommended to store it in a dark place as light can affect its efficacy. It is expected to remain active for 2 years after mixing. It should not be refrigerated or frozen.